Fig. 4.
Fig. 4. Immunoprecipitation of variant A2 domain fragments by isolated scFv. / Binding of scFv to recombinant A2 domain and A2-FV484-508 was assessed by immunoprecipitation. Lane 1, positive control (mAb CLB–CAg 9); lane 2, negative control (normal plasma); lane 3, scFv VK34; lane 4, scFv VK41; lane 5, scFv EL-14, directed toward the C2 domain of factor VIII. Molecular weight markers (in kd) are indicated at the right.

Immunoprecipitation of variant A2 domain fragments by isolated scFv.

Binding of scFv to recombinant A2 domain and A2-FV484-508 was assessed by immunoprecipitation. Lane 1, positive control (mAb CLB–CAg 9); lane 2, negative control (normal plasma); lane 3, scFv VK34; lane 4, scFv VK41; lane 5, scFv EL-14, directed toward the C2 domain of factor VIII. Molecular weight markers (in kd) are indicated at the right.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal